I kontrollerede kliniske studier forekom angioødem sjældent under behandling med Riprazo, og havde sammenlignelig hyppighed med placebo eller hydrochlorthiazid.
In controlled clinical trials, angioedema occurred rarely during treatment with Riprazo with rates comparable to treatment with placebo or hydrochlorothiazide.